The FDA has approved AstraZeneca's Imfinzi with gemcitabine and cisplatin as neoadjuvant treatment in adults with MIBC.

AstraZeneca (AZ) has announced that its Imfinzi (durvalumab) perioperative regimen has been approved by the US Food and Drug ...

AstraZeneca AZN announced that the FDA has approved its blockbuster drug, Imfinzi (durvalumab), for a bladder cancer ...

Here is a roundup of March 2025 U.S. FDA approvals across cancer subtypes, including prostate, bladder and gastrointestinal ...

ABOUT 55,000 new prostate cancer cases are recorded every year in the UK. Bladder cancer is less common, with around 10,500 ...

Learn the 7 vital bladder cancer warning signs that require immediate medical attention, including subtle early symptoms many ...

【导读】虽然厄达替尼在膀胱癌治疗中展现了良好的效果，但其耐药性的问题不容忽视。近日，华中科技大学的研究团队在《Advanced Science》期刊上发布了重要研究，题为“Targeting COPA to Enhance Erdafitinib Sensitivity in FGFR-Altered Bladder ...

Imfinzi was generally well tolerated, and no new safety signals were observed in the neoadjuvant and adjuvant settings.

AstraZeneca has secured another expansion of its Imfinzi for use in cancer patients before and after surgery. | Imfinzi is ...

Eddie Jordan, the Formula 1 legend, died on Thursday in Cape Town, South Africa following a journey with bladder cancer, ...

The promotional effort from Ferring features bladder cancer survivors sharing the news of a new treatment option.

Bladder cancer spreads at different speeds depending on the type of bladder cancer you have. Urothelial bladder cancer is slow to spread, while other types are much faster. Urothelial bladder ...